Non-alcoholic and alcoholic Fatty Liver Disease - two Diseases of Affluence associated with the Metabolic Syndrome and Type 2 Diabetes: the FIN-D2D Survey
Background Non-alcoholic fatty liver disease (NAFLD) is known to be associated with the metabolic syndrome (MetS) and abnormal glucose tolerance. Whether alcoholic fatty liver disease (AFLD) is associated with similar metabolic abnormalities has not been examined in a population-based study. We aime...
Gespeichert in:
| Veröffentlicht in: | BMC public health Jg. 10; H. 1; S. 237 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
London
BioMed Central
10.05.2010
BioMed Central Ltd Springer Nature B.V BMC |
| Schlagworte: | |
| ISSN: | 1471-2458, 1471-2458 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Background
Non-alcoholic fatty liver disease (NAFLD) is known to be associated with the metabolic syndrome (MetS) and abnormal glucose tolerance. Whether alcoholic fatty liver disease (AFLD) is associated with similar metabolic abnormalities has not been examined in a population-based study. We aimed at assessing the prevalences of NAFLD and AFLD, and to examine to what extent these conditions are associated with MetS and abnormal glucose tolerance.
Methods
The cohort included 2766 Finnish subjects (45-74 years) from the population-based FIN-D2D survey. Features of insulin resistance, components of the MetS, glucose tolerance status by oral glucose tolerance test, serum liver enzyme concentrations, and daily alcohol consumption were assessed.
Results
Subjects with NAFLD and AFLD were equally obese and had similar fasting and insulin concentrations. The prevalences of NAFLD and AFLD were 21% (95% CI: 19%-22%) and 7% (95% CI: 6%-8%). The MetS was slightly more prevalent in AFLD (73%) than in NAFLD (70%, p = 0.028), and type 2 diabetes was similarly prevalent in NAFLD and AFLD (24-25%). The MetS and type 2 diabetes were more prevalent in subjects with NAFLD or AFLD compared to subjects with normal LFTs (53% and 14%, p < 0.0001 for both).
Discussion and conclusion
In Finnish middle-aged population, the prevalence of NAFLD is 3-fold higher than that of AFLD. The prevalences of MetS and type 2 diabetes are, however, significantly increased in both NAFLD and AFLD compared to subjects with normal LFTs. Subjects with AFLD are thus similarly metabolically unhealthy as subjects with NAFLD. |
|---|---|
| AbstractList | Background Non-alcoholic fatty liver disease (NAFLD) is known to be associated with the metabolic syndrome (MetS) and abnormal glucose tolerance. Whether alcoholic fatty liver disease (AFLD) is associated with similar metabolic abnormalities has not been examined in a population-based study. We aimed at assessing the prevalences of NAFLD and AFLD, and to examine to what extent these conditions are associated with MetS and abnormal glucose tolerance. Methods The cohort included 2766 Finnish subjects (45-74 years) from the population-based FIN-D2D survey. Features of insulin resistance, components of the MetS, glucose tolerance status by oral glucose tolerance test, serum liver enzyme concentrations, and daily alcohol consumption were assessed. Results Subjects with NAFLD and AFLD were equally obese and had similar fasting and insulin concentrations. The prevalences of NAFLD and AFLD were 21% (95% CI: 19%-22%) and 7% (95% CI: 6%-8%). The MetS was slightly more prevalent in AFLD (73%) than in NAFLD (70%, p = 0.028), and type 2 diabetes was similarly prevalent in NAFLD and AFLD (24-25%). The MetS and type 2 diabetes were more prevalent in subjects with NAFLD or AFLD compared to subjects with normal LFTs (53% and 14%, p [less than] 0.0001 for both). Discussion and conclusion In Finnish middle-aged population, the prevalence of NAFLD is 3-fold higher than that of AFLD. The prevalences of MetS and type 2 diabetes are, however, significantly increased in both NAFLD and AFLD compared to subjects with normal LFTs. Subjects with AFLD are thus similarly metabolically unhealthy as subjects with NAFLD. Abstract Background Non-alcoholic fatty liver disease (NAFLD) is known to be associated with the metabolic syndrome (MetS) and abnormal glucose tolerance. Whether alcoholic fatty liver disease (AFLD) is associated with similar metabolic abnormalities has not been examined in a population-based study. We aimed at assessing the prevalences of NAFLD and AFLD, and to examine to what extent these conditions are associated with MetS and abnormal glucose tolerance. Methods The cohort included 2766 Finnish subjects (45-74 years) from the population-based FIN-D2D survey. Features of insulin resistance, components of the MetS, glucose tolerance status by oral glucose tolerance test, serum liver enzyme concentrations, and daily alcohol consumption were assessed. Results Subjects with NAFLD and AFLD were equally obese and had similar fasting and insulin concentrations. The prevalences of NAFLD and AFLD were 21% (95% CI: 19%-22%) and 7% (95% CI: 6%-8%). The MetS was slightly more prevalent in AFLD (73%) than in NAFLD (70%, p = 0.028), and type 2 diabetes was similarly prevalent in NAFLD and AFLD (24-25%). The MetS and type 2 diabetes were more prevalent in subjects with NAFLD or AFLD compared to subjects with normal LFTs (53% and 14%, p < 0.0001 for both). Discussion and conclusion In Finnish middle-aged population, the prevalence of NAFLD is 3-fold higher than that of AFLD. The prevalences of MetS and type 2 diabetes are, however, significantly increased in both NAFLD and AFLD compared to subjects with normal LFTs. Subjects with AFLD are thus similarly metabolically unhealthy as subjects with NAFLD. Non-alcoholic fatty liver disease (NAFLD) is known to be associated with the metabolic syndrome (MetS) and abnormal glucose tolerance. Whether alcoholic fatty liver disease (AFLD) is associated with similar metabolic abnormalities has not been examined in a population-based study. We aimed at assessing the prevalences of NAFLD and AFLD, and to examine to what extent these conditions are associated with MetS and abnormal glucose tolerance. The cohort included 2766 Finnish subjects (45-74 years) from the population-based FIN-D2D survey. Features of insulin resistance, components of the MetS, glucose tolerance status by oral glucose tolerance test, serum liver enzyme concentrations, and daily alcohol consumption were assessed. Subjects with NAFLD and AFLD were equally obese and had similar fasting and insulin concentrations. The prevalences of NAFLD and AFLD were 21% (95% CI: 19%-22%) and 7% (95% CI: 6%-8%). The MetS was slightly more prevalent in AFLD (73%) than in NAFLD (70%, p = 0.028), and type 2 diabetes was similarly prevalent in NAFLD and AFLD (24-25%). The MetS and type 2 diabetes were more prevalent in subjects with NAFLD or AFLD compared to subjects with normal LFTs (53% and 14%, p [less than] 0.0001 for both). In Finnish middle-aged population, the prevalence of NAFLD is 3-fold higher than that of AFLD. The prevalences of MetS and type 2 diabetes are, however, significantly increased in both NAFLD and AFLD compared to subjects with normal LFTs. Subjects with AFLD are thus similarly metabolically unhealthy as subjects with NAFLD. Background Non-alcoholic fatty liver disease (NAFLD) is known to be associated with the metabolic syndrome (MetS) and abnormal glucose tolerance. Whether alcoholic fatty liver disease (AFLD) is associated with similar metabolic abnormalities has not been examined in a population-based study. We aimed at assessing the prevalences of NAFLD and AFLD, and to examine to what extent these conditions are associated with MetS and abnormal glucose tolerance. Methods The cohort included 2766 Finnish subjects (45-74 years) from the population-based FIN-D2D survey. Features of insulin resistance, components of the MetS, glucose tolerance status by oral glucose tolerance test, serum liver enzyme concentrations, and daily alcohol consumption were assessed. Results Subjects with NAFLD and AFLD were equally obese and had similar fasting and insulin concentrations. The prevalences of NAFLD and AFLD were 21% (95% CI: 19%-22%) and 7% (95% CI: 6%-8%). The MetS was slightly more prevalent in AFLD (73%) than in NAFLD (70%, p = 0.028), and type 2 diabetes was similarly prevalent in NAFLD and AFLD (24-25%). The MetS and type 2 diabetes were more prevalent in subjects with NAFLD or AFLD compared to subjects with normal LFTs (53% and 14%, p < 0.0001 for both). Discussion and conclusion In Finnish middle-aged population, the prevalence of NAFLD is 3-fold higher than that of AFLD. The prevalences of MetS and type 2 diabetes are, however, significantly increased in both NAFLD and AFLD compared to subjects with normal LFTs. Subjects with AFLD are thus similarly metabolically unhealthy as subjects with NAFLD. Non-alcoholic fatty liver disease (NAFLD) is known to be associated with the metabolic syndrome (MetS) and abnormal glucose tolerance. Whether alcoholic fatty liver disease (AFLD) is associated with similar metabolic abnormalities has not been examined in a population-based study. We aimed at assessing the prevalences of NAFLD and AFLD, and to examine to what extent these conditions are associated with MetS and abnormal glucose tolerance.BACKGROUNDNon-alcoholic fatty liver disease (NAFLD) is known to be associated with the metabolic syndrome (MetS) and abnormal glucose tolerance. Whether alcoholic fatty liver disease (AFLD) is associated with similar metabolic abnormalities has not been examined in a population-based study. We aimed at assessing the prevalences of NAFLD and AFLD, and to examine to what extent these conditions are associated with MetS and abnormal glucose tolerance.The cohort included 2766 Finnish subjects (45-74 years) from the population-based FIN-D2D survey. Features of insulin resistance, components of the MetS, glucose tolerance status by oral glucose tolerance test, serum liver enzyme concentrations, and daily alcohol consumption were assessed.METHODSThe cohort included 2766 Finnish subjects (45-74 years) from the population-based FIN-D2D survey. Features of insulin resistance, components of the MetS, glucose tolerance status by oral glucose tolerance test, serum liver enzyme concentrations, and daily alcohol consumption were assessed.Subjects with NAFLD and AFLD were equally obese and had similar fasting and insulin concentrations. The prevalences of NAFLD and AFLD were 21% (95% CI: 19%-22%) and 7% (95% CI: 6%-8%). The MetS was slightly more prevalent in AFLD (73%) than in NAFLD (70%, p = 0.028), and type 2 diabetes was similarly prevalent in NAFLD and AFLD (24-25%). The MetS and type 2 diabetes were more prevalent in subjects with NAFLD or AFLD compared to subjects with normal LFTs (53% and 14%, p < 0.0001 for both).RESULTSSubjects with NAFLD and AFLD were equally obese and had similar fasting and insulin concentrations. The prevalences of NAFLD and AFLD were 21% (95% CI: 19%-22%) and 7% (95% CI: 6%-8%). The MetS was slightly more prevalent in AFLD (73%) than in NAFLD (70%, p = 0.028), and type 2 diabetes was similarly prevalent in NAFLD and AFLD (24-25%). The MetS and type 2 diabetes were more prevalent in subjects with NAFLD or AFLD compared to subjects with normal LFTs (53% and 14%, p < 0.0001 for both).In Finnish middle-aged population, the prevalence of NAFLD is 3-fold higher than that of AFLD. The prevalences of MetS and type 2 diabetes are, however, significantly increased in both NAFLD and AFLD compared to subjects with normal LFTs. Subjects with AFLD are thus similarly metabolically unhealthy as subjects with NAFLD.DISCUSSION AND CONCLUSIONIn Finnish middle-aged population, the prevalence of NAFLD is 3-fold higher than that of AFLD. The prevalences of MetS and type 2 diabetes are, however, significantly increased in both NAFLD and AFLD compared to subjects with normal LFTs. Subjects with AFLD are thus similarly metabolically unhealthy as subjects with NAFLD. Non-alcoholic fatty liver disease (NAFLD) is known to be associated with the metabolic syndrome (MetS) and abnormal glucose tolerance. Whether alcoholic fatty liver disease (AFLD) is associated with similar metabolic abnormalities has not been examined in a population-based study. We aimed at assessing the prevalences of NAFLD and AFLD, and to examine to what extent these conditions are associated with MetS and abnormal glucose tolerance. The cohort included 2766 Finnish subjects (45-74 years) from the population-based FIN-D2D survey. Features of insulin resistance, components of the MetS, glucose tolerance status by oral glucose tolerance test, serum liver enzyme concentrations, and daily alcohol consumption were assessed. Subjects with NAFLD and AFLD were equally obese and had similar fasting and insulin concentrations. The prevalences of NAFLD and AFLD were 21% (95% CI: 19%-22%) and 7% (95% CI: 6%-8%). The MetS was slightly more prevalent in AFLD (73%) than in NAFLD (70%, p = 0.028), and type 2 diabetes was similarly prevalent in NAFLD and AFLD (24-25%). The MetS and type 2 diabetes were more prevalent in subjects with NAFLD or AFLD compared to subjects with normal LFTs (53% and 14%, p < 0.0001 for both). In Finnish middle-aged population, the prevalence of NAFLD is 3-fold higher than that of AFLD. The prevalences of MetS and type 2 diabetes are, however, significantly increased in both NAFLD and AFLD compared to subjects with normal LFTs. Subjects with AFLD are thus similarly metabolically unhealthy as subjects with NAFLD. |
| ArticleNumber | 237 |
| Audience | Academic |
| Author | Saaristo, Timo Saarikoski, Liisa Kotronen, Anna Männistö, Satu Yki-Järvinen, Hannele Oksa, Heikki Saltevo, Juha Tuomilehto, Jaakko Korpi-Hyövälti, Eeva Sundvall, Jouko Peltonen, Markku |
| AuthorAffiliation | 4 Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland 6 Tampere University Hospital, Tampere, Finland 8 Laboratory of Analytical Biochemistry, Department of Health and Functional Capacity, National Institute for Health and Welfare, Helsinki Finland 3 Minerva Medical Research Institute, Helsinki, Finland 9 Department of Public Health, University of Helsinki, Finland 1 Diabetes Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland 7 Department of Internal Medicine, Central Finland Central Hospital, Jyväskylä, Finland 2 Department of Medicine, Division of Diabetes, University of Helsinki, Helsinki, Finland 5 Department of Internal Medicine, South Ostrobothnia Central Hospital, Seinäjoki, Finland |
| AuthorAffiliation_xml | – name: 4 Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland – name: 3 Minerva Medical Research Institute, Helsinki, Finland – name: 2 Department of Medicine, Division of Diabetes, University of Helsinki, Helsinki, Finland – name: 5 Department of Internal Medicine, South Ostrobothnia Central Hospital, Seinäjoki, Finland – name: 1 Diabetes Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland – name: 9 Department of Public Health, University of Helsinki, Finland – name: 7 Department of Internal Medicine, Central Finland Central Hospital, Jyväskylä, Finland – name: 8 Laboratory of Analytical Biochemistry, Department of Health and Functional Capacity, National Institute for Health and Welfare, Helsinki Finland – name: 6 Tampere University Hospital, Tampere, Finland |
| Author_xml | – sequence: 1 givenname: Anna surname: Kotronen fullname: Kotronen, Anna email: anna.kotronen@helsinki.fi organization: Diabetes Prevention Unit, National Institute for Health and Welfare, Department of Medicine, Division of Diabetes, University of Helsinki, Minerva Medical Research Institute – sequence: 2 givenname: Hannele surname: Yki-Järvinen fullname: Yki-Järvinen, Hannele organization: Department of Medicine, Division of Diabetes, University of Helsinki – sequence: 3 givenname: Satu surname: Männistö fullname: Männistö, Satu organization: Department of Chronic Disease Prevention, National Institute for Health and Welfare – sequence: 4 givenname: Liisa surname: Saarikoski fullname: Saarikoski, Liisa organization: Diabetes Prevention Unit, National Institute for Health and Welfare – sequence: 5 givenname: Eeva surname: Korpi-Hyövälti fullname: Korpi-Hyövälti, Eeva organization: Department of Internal Medicine, South Ostrobothnia Central Hospital – sequence: 6 givenname: Heikki surname: Oksa fullname: Oksa, Heikki organization: Tampere University Hospital – sequence: 7 givenname: Juha surname: Saltevo fullname: Saltevo, Juha organization: Department of Internal Medicine, Central Finland Central Hospital – sequence: 8 givenname: Timo surname: Saaristo fullname: Saaristo, Timo organization: Tampere University Hospital – sequence: 9 givenname: Jouko surname: Sundvall fullname: Sundvall, Jouko organization: Laboratory of Analytical Biochemistry, Department of Health and Functional Capacity, National Institute for Health and Welfare – sequence: 10 givenname: Jaakko surname: Tuomilehto fullname: Tuomilehto, Jaakko organization: Department of Public Health, University of Helsinki – sequence: 11 givenname: Markku surname: Peltonen fullname: Peltonen, Markku organization: Diabetes Prevention Unit, National Institute for Health and Welfare |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20459722$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kktvEzEUhUeoiD5gzwpZsGA1xY95mQVS1BCIFMqiZW157OvE0WTc2k6q_BV-LU7StE0FaBYzvvOdYx_rnGZHveshy94SfE5IU30iRU1yWpRNTnBOWf0iO3kYHT35Ps5OQ5hjTOqmpK-yY4qLkteUnmS_L12fy065meusQrLX6HE1kjGu0cSuwKOhDSADoBzFO7dfBeQMGhjTLaFXgGQITlkZQaM7G2cozgD9gCjbrdvVutfeLWC7yfX6BhBNPrKFCOHzlh2NL_MhHaKrpV_B-nX20sguwJv791n2a_T1-uJ7Pvn5bXwxmOQqZYi5aVqeYpVtK0kKTKXiHKAumGkJqAZrpSteSWNoYzi0pjSmrTUHxSTj2ih2lo13vtrJubjxdiH9WjhpxXbg_FRIH63qQNDatE1dEox5VUDZ8EZi1mqiKUhMa528vuy8bpbtArSCPnrZHZge_untTEzdStCmZpzVyeDjvYF3t0sIUSxsUNB1sge3DKJmrCxZU-FEvn9Gzt3S9-mmBMeUcMwKmqAPO2gq0_Ftb1zaVW0sxYDSqmGc0CJR53-h0qNhYVWqnLFpfiB49zTmQ759rxJQ7QDlXQgejFA2ymjdJrXtBMFiU2CxaajYNHQzodv8-Jlw7_0fCdlJQkL7KfjHi_in5g8yaACR |
| CitedBy_id | crossref_primary_10_5812_ircmj_12669 crossref_primary_10_2196_30066 crossref_primary_10_14309_ajg_0000000000000833 crossref_primary_10_1097_CEH_0000000000000506 crossref_primary_10_1210_clinem_dgad418 crossref_primary_10_1007_s11739_012_0824_7 crossref_primary_10_1177_0300060513517485 crossref_primary_10_1016_j_cld_2024_06_002 crossref_primary_10_1111_apt_12673 crossref_primary_10_1530_JOE_16_0513 crossref_primary_10_1371_journal_pone_0076813 crossref_primary_10_3350_cmh_2014_20_2_154 crossref_primary_10_1016_j_hbpd_2022_10_003 crossref_primary_10_1002_cbf_2867 crossref_primary_10_1002_ijc_25797 crossref_primary_10_5812_hepatmon_25067 crossref_primary_10_1016_j_actbio_2024_06_014 crossref_primary_10_1002_hep_29247 crossref_primary_10_1186_s12944_015_0072_8 crossref_primary_10_1002_hep_28431 crossref_primary_10_1002_jcu_23398 crossref_primary_10_1007_s12072_013_9430_7 crossref_primary_10_3389_fphys_2016_00430 crossref_primary_10_14400_JDC_2014_12_3_345 crossref_primary_10_1055_a_1862_9088 crossref_primary_10_1155_2019_9727952 crossref_primary_10_1038_s41598_018_28563_y crossref_primary_10_1016_j_atherosclerosis_2012_10_049 crossref_primary_10_1002_kjm2_12744 crossref_primary_10_3389_fendo_2018_00341 crossref_primary_10_1371_journal_pone_0060495 crossref_primary_10_3109_07853890_2014_966752 crossref_primary_10_1016_j_jhep_2019_01_035 crossref_primary_10_1038_srep38262 crossref_primary_10_1016_j_bbrc_2018_04_107 crossref_primary_10_1016_j_lpm_2019_08_008 crossref_primary_10_1002_1348_9585_12109 crossref_primary_10_1097_MOG_0000000000000627 crossref_primary_10_1097_HC9_0000000000000133 crossref_primary_10_1016_j_jhep_2017_11_006 crossref_primary_10_3390_nu11123048 crossref_primary_10_1002_gepi_21895 crossref_primary_10_1155_2014_903258 crossref_primary_10_1186_s12916_024_03315_0 crossref_primary_10_1038_s41598_020_66770_8 crossref_primary_10_1159_000375506 crossref_primary_10_1002_hep_30804 crossref_primary_10_1371_journal_pone_0171502 crossref_primary_10_14309_ajg_0000000000001141 crossref_primary_10_3390_mps5010001 crossref_primary_10_1016_j_jceh_2017_09_002 crossref_primary_10_1080_07420528_2021_1899198 |
| Cites_doi | 10.3181/00379727-176-4-RC2 10.1055/s-2005-861411 10.1210/jc.2004-2240 10.1152/ajpendo.00064.2004 10.1111/j.1572-0241.1999.01006.x 10.1016/j.bpg.2004.06.021 10.1097/00004836-200311000-00010 10.1016/0895-4356(88)90084-4 10.1002/hep.20734 10.1016/S0016-5085(99)70506-8 10.1210/jc.2007-0482 10.1016/0021-9150(86)90090-0 10.1002/hep.21496 10.1111/j.1572-0241.2003.07486.x 10.1111/j.1572-0241.2005.41500.x 10.1136/gut.2003.019984 10.1186/1471-2458-8-423 10.1093/qjmed/89.2.137 10.1161/ATVBAHA.107.147538 10.1053/jhep.2003.50193 10.3402/ijch.v66i2.18239 10.1016/S0140-6736(05)67402-8 10.7326/0003-4819-137-1-200207020-00006 10.1161/ATVBAHA.107.151092 10.1093/clinchem/18.6.499 |
| ContentType | Journal Article |
| Copyright | Kotronen et al; licensee BioMed Central Ltd. 2010 COPYRIGHT 2010 BioMed Central Ltd. 2010 Kotronen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright ©2010 Kotronen et al; licensee BioMed Central Ltd. 2010 Kotronen et al; licensee BioMed Central Ltd. |
| Copyright_xml | – notice: Kotronen et al; licensee BioMed Central Ltd. 2010 – notice: COPYRIGHT 2010 BioMed Central Ltd. – notice: 2010 Kotronen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: Copyright ©2010 Kotronen et al; licensee BioMed Central Ltd. 2010 Kotronen et al; licensee BioMed Central Ltd. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T2 7X7 7XB 88E 8C1 8FE 8FG 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA AN0 ATCPS AZQEC BENPR BGLVJ BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. L6V M0S M1P M7S PATMY PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY 7X8 5PM DOA |
| DOI | 10.1186/1471-2458-10-237 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health and Safety Science Abstracts (Full archive) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database ProQuest SciTech Collection ProQuest Technology Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) One Sustainability ProQuest Central UK/Ireland British Nursing Database Agricultural & Environmental Science Collection ProQuest Central Essentials ProQuest Central Technology collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Engineering Collection ProQuest Health & Medical Collection Medical Database Engineering Database (Proquest) Environmental Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection (ProQuest) Environmental Science Collection MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Technology Collection ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection ProQuest Engineering Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Agricultural & Environmental Science Collection Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Engineering Database ProQuest Public Health ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Environmental Science Collection ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Materials Science & Engineering Collection Environmental Science Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: ProQuest Publicly Available Content url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1471-2458 |
| EndPage | 237 |
| ExternalDocumentID | oai_doaj_org_article_27fb875100964e5898a03bd1d2ea027d PMC2873937 2502976091 A226839124 20459722 10_1186_1471_2458_10_237 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Finland |
| GeographicLocations_xml | – name: Finland |
| GroupedDBID | --- 0R~ 23N 2VQ 2WC 2XV 4.4 44B 53G 5VS 6J9 6PF 7X7 7XC 88E 8C1 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAJSJ AASML AAWTL ABDBF ABJCF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AN0 AOIJS ATCPS BAPOH BAWUL BCNDV BENPR BFQNJ BGLVJ BHPHI BMC BNQBC BPHCQ BVXVI C1A C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESTFP ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HMCUK HYE IAO IHR INH INR IPNFZ ITC KQ8 L6V M1P M48 M7S M~E O5R O5S OK1 OVT P2P PATMY PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PTHSS PUEGO PYCSY RBZ RIG RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB AAYXX AFFHD CITATION ALIPV CGR CUY CVF ECM EIF NPM 3V. 7T2 7XB 8FK AZQEC C1K DWQXO GNUQQ K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c597t-f8b97855bba11472ac99ee743fb1ec80dcd696aff28f9ebf5ffb7d9ec3a39dfc3 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 52 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000278254500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1471-2458 |
| IngestDate | Fri Oct 03 12:50:57 EDT 2025 Tue Nov 04 01:59:52 EST 2025 Wed Oct 01 14:24:46 EDT 2025 Sat Oct 11 05:43:08 EDT 2025 Tue Nov 11 07:36:14 EST 2025 Sat Nov 29 10:02:38 EST 2025 Thu Apr 03 07:00:52 EDT 2025 Sat Nov 29 02:49:17 EST 2025 Tue Nov 18 21:15:07 EST 2025 Sat Sep 06 07:28:43 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Oral Glucose Tolerance Test Abnormal Glucose Tolerance Proton Magnetic Resonance Spectroscopy High Alcohol Consumption Metabolic Syndrome |
| Language | English |
| License | http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c597t-f8b97855bba11472ac99ee743fb1ec80dcd696aff28f9ebf5ffb7d9ec3a39dfc3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://link.springer.com/10.1186/1471-2458-10-237 |
| PMID | 20459722 |
| PQID | 902190342 |
| PQPubID | 44782 |
| PageCount | 1 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_27fb875100964e5898a03bd1d2ea027d pubmedcentral_primary_oai_pubmedcentral_nih_gov_2873937 proquest_miscellaneous_733553860 proquest_journals_902190342 gale_infotracmisc_A226839124 gale_infotracacademiconefile_A226839124 pubmed_primary_20459722 crossref_citationtrail_10_1186_1471_2458_10_237 crossref_primary_10_1186_1471_2458_10_237 springer_journals_10_1186_1471_2458_10_237 |
| PublicationCentury | 2000 |
| PublicationDate | 2010-05-10 |
| PublicationDateYYYYMMDD | 2010-05-10 |
| PublicationDate_xml | – month: 05 year: 2010 text: 2010-05-10 day: 10 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC public health |
| PublicationTitleAbbrev | BMC Public Health |
| PublicationTitleAlternate | BMC Public Health |
| PublicationYear | 2010 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | Sharpe, McBride, Archbold (CR8) 1996; 89 Matteoni, Younossi, Gramlich, Boparai, Liu, McCullough (CR18) 1999; 116 Bedogni, Miglioli, Masutti, Tiribelli, Marchesini, Bellentani (CR17) 2005; 42 Saaristo, Barengo, Korpi-Hyovalti, Oksa, Puolijoki, Saltevo, Vanhala, Sundvall, Saarikoski, Peltonen, Tuomilehto (CR30) 2008; 8 Grundy (CR22) 2008; 28 Dam-Larsen, Franzmann, Andersen, Christoffersen, Jensen, Sorensen, Becker, Bendtsen (CR6) 2004; 53 Sorbi, Boynton, Lindor (CR21) 1999; 94 Alberti, Zimmet, Shaw (CR13) 2005; 366 Wannamethee, Shaper (CR25) 1991; 5 Saaristo, Peltonen, Keinanen-Kiukaanniemi, Vanhala, Saltevo, Niskanen, Oksa, Korpi-Hyovalti, Tuomilehto (CR29) 2007; 66 (CR12) 1999 Prati, Taioli, Zanella, Della Torre, Butelli, Del Vecchio, Vianello, Zanuso, Mozzi, Milani, Conte, Colombo, Sirchia (CR16) 2002; 137 Masarei, Puddey, Rouse, Lynch, Vandongen, Beilin (CR24) 1986; 60 Szczepaniak, Nurenberg, Leonard, Browning, Reingold, Grundy, Hobbs, Dobbins (CR3) 2005; 288 Kotronen, Yki-Jarvinen (CR26) 2008; 28 Bugianesi, Pagotto, Manini, Vanni, Gastaldelli, de Iasio, Gentilcore, Natale, Cassader, Rizzetto, Pasquali, Marchesini (CR19) 2005; 90 (CR15) 2005 Jepsen, Vilstrup, Mellemkjaer, Thulstrup, Olsen, Baron, Sorensen (CR7) 2003; 50 Neuschwander-Tetri, Caldwell (CR1) 2003; 37 Clark (CR4) 2006; 40 Sargin, Uygur-Bayramicli, Sargin, Orbay, Yayla (CR27) 2003; 37 (CR10) 1988; 41 Friedewald, Levy, Fredrickson (CR14) 1972; 18 Yesilova, Yaman, Oktenli, Ozcan, Uygun, Cakir, Sanisoglu, Erdil, Ates, Aslan, Musabak, Erbil, Karaeren, Dagalp (CR20) 2005; 100 Thamer, Tschritter, Haap, Shirkavand, Machann, Fritsche, Schick, Haring, Stumvoll (CR9) 2005; 37 Angulo, Hui, Marchesini, Bugianesi, George, Farrell, Enders, Saksena, Burt, Bida, Lindor, Sanderson, Lenzi, Adams, Kench, Therneau, Day (CR28) 2007; 45 Kotronen, Westerbacka, Bergholm, Pietilainen, Yki-Jarvinen (CR11) 2007; 92 Cluette, Mulligan, Noring, Doyle, Hojnacki (CR23) 1984; 176 Cortez-Pinto, Camilo (CR5) 2004; 18 Clark, Brancati, Diehl (CR2) 2003; 98 M Sargin (2148_CR27) 2003; 37 JM Clark (2148_CR2) 2003; 98 C Thamer (2148_CR9) 2005; 37 JR Masarei (2148_CR24) 1986; 60 TE Saaristo (2148_CR30) 2008; 8 Anonymous (2148_CR10) 1988; 41 H Cortez-Pinto (2148_CR5) 2004; 18 PC Sharpe (2148_CR8) 1996; 89 A Kotronen (2148_CR11) 2007; 92 JE Cluette (2148_CR23) 1984; 176 BA Neuschwander-Tetri (2148_CR1) 2003; 37 JM Clark (2148_CR4) 2006; 40 WT Friedewald (2148_CR14) 1972; 18 Anonymous (2148_CR15) 2005 D Prati (2148_CR16) 2002; 137 LS Szczepaniak (2148_CR3) 2005; 288 D Sorbi (2148_CR21) 1999; 94 S Dam-Larsen (2148_CR6) 2004; 53 T Saaristo (2148_CR29) 2007; 66 G Wannamethee (2148_CR25) 1991; 5 P Jepsen (2148_CR7) 2003; 50 A Kotronen (2148_CR26) 2008; 28 P Angulo (2148_CR28) 2007; 45 SM Grundy (2148_CR22) 2008; 28 KG Alberti (2148_CR13) 2005; 366 Z Yesilova (2148_CR20) 2005; 100 G Bedogni (2148_CR17) 2005; 42 CA Matteoni (2148_CR18) 1999; 116 E Bugianesi (2148_CR19) 2005; 90 WHO Consultation (2148_CR12) 1999 1677046 - J Hum Hypertens. 1991 Apr;5(2):59-67 18174459 - Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):629-36 16182882 - Lancet. 2005 Sep 24-30;366(9491):1059-62 12093239 - Ann Intern Med. 2002 Jul 2;137(1):1-10 12717402 - Hepatology. 2003 May;37(5):1202-19 8729555 - QJM. 1996 Feb;89(2):137-44 19113993 - BMC Public Health. 2008;8:423 17515250 - Int J Circumpolar Health. 2007 Apr;66(2):101-12 17690317 - Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):27-38 12809815 - Am J Gastroenterol. 2003 May;98(5):960-7 14696473 - Hepatogastroenterology. 2003 Nov-Dec;50(54):2101-4 10348825 - Gastroenterology. 1999 Jun;116(6):1413-9 15952086 - Horm Metab Res. 2005 Apr;37(4):246-51 14564188 - J Clin Gastroenterol. 2003 Nov-Dec;37(5):399-402 3707675 - Atherosclerosis. 1986 Apr;60(1):79-87 6463061 - Proc Soc Exp Biol Med. 1984 Sep;176(4):508-11 4337382 - Clin Chem. 1972 Jun;18(6):499-502 17393509 - Hepatology. 2007 Apr;45(4):846-54 15339742 - Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E462-8 15082596 - Gut. 2004 May;53(5):750-5 15561640 - Best Pract Res Clin Gastroenterol. 2004 Dec;18(6):1089-104 15797948 - J Clin Endocrinol Metab. 2005 Jun;90(6):3498-504 3335877 - J Clin Epidemiol. 1988;41(2):105-14 15784031 - Am J Gastroenterol. 2005 Apr;100(4):850-5 10201476 - Am J Gastroenterol. 1999 Apr;94(4):1018-22 17595248 - J Clin Endocrinol Metab. 2007 Sep;92(9):3490-7 16540768 - J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S5-10 15895401 - Hepatology. 2005 Jul;42(1):44-52 |
| References_xml | – volume: 176 start-page: 508 issue: 4 year: 1984 end-page: 511 ident: CR23 article-title: Ethanol enhances de novo synthesis of high density lipoprotein cholesterol publication-title: Proc Soc Exp Biol Med doi: 10.3181/00379727-176-4-RC2 – volume: 37 start-page: 246 issue: 4 year: 2005 end-page: 251 ident: CR9 article-title: Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids publication-title: Horm Metab Res doi: 10.1055/s-2005-861411 – volume: 90 start-page: 3498 issue: 6 year: 2005 end-page: 3504 ident: CR19 article-title: Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2004-2240 – volume: 288 start-page: E462 issue: 2 year: 2005 end-page: 8 ident: CR3 article-title: Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00064.2004 – volume: 94 start-page: 1018 issue: 4 year: 1999 end-page: 1022 ident: CR21 article-title: The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.1999.01006.x – volume: 18 start-page: 1089 issue: 6 year: 2004 end-page: 1104 ident: CR5 article-title: Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course publication-title: Best Pract Res Clin Gastroenterol doi: 10.1016/j.bpg.2004.06.021 – volume: 37 start-page: 399 issue: 5 year: 2003 end-page: 402 ident: CR27 article-title: Association of nonalcoholic fatty liver disease with insulin resistance: is OGTT indicated in nonalcoholic fatty liver disease? publication-title: J Clin Gastroenterol doi: 10.1097/00004836-200311000-00010 – volume: 40 start-page: S5 issue: 3 Suppl 1 year: 2006 end-page: 10 ident: CR4 article-title: The epidemiology of nonalcoholic fatty liver disease in adults publication-title: J Clin Gastroenterol – volume: 41 start-page: 105 issue: 2 year: 1988 end-page: 114 ident: CR10 article-title: The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators publication-title: J Clin Epidemiol doi: 10.1016/0895-4356(88)90084-4 – volume: 42 start-page: 44 issue: 1 year: 2005 end-page: 52 ident: CR17 article-title: Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study publication-title: Hepatology doi: 10.1002/hep.20734 – volume: 116 start-page: 1413 issue: 6 year: 1999 end-page: 1419 ident: CR18 article-title: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity publication-title: Gastroenterology doi: 10.1016/S0016-5085(99)70506-8 – volume: 92 start-page: 3490 issue: 9 year: 2007 end-page: 3497 ident: CR11 article-title: Liver fat in the metabolic syndrome publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2007-0482 – volume: 60 start-page: 79 issue: 1 year: 1986 end-page: 87 ident: CR24 article-title: Effects of alcohol consumption on serum lipoprotein-lipid and apolipoprotein concentrations. Results from an intervention study in healthy subjects publication-title: Atherosclerosis doi: 10.1016/0021-9150(86)90090-0 – year: 1999 ident: CR12 publication-title: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus – volume: 45 start-page: 846 issue: 4 year: 2007 end-page: 854 ident: CR28 article-title: The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD publication-title: Hepatology doi: 10.1002/hep.21496 – volume: 98 start-page: 960 issue: 5 year: 2003 end-page: 967 ident: CR2 article-title: The prevalence and etiology of elevated aminotransferase levels in the United States publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2003.07486.x – volume: 100 start-page: 850 issue: 4 year: 2005 end-page: 855 ident: CR20 article-title: Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2005.41500.x – volume: 53 start-page: 750 issue: 5 year: 2004 end-page: 755 ident: CR6 article-title: Long term prognosis of fatty liver: risk of chronic liver disease and death publication-title: Gut doi: 10.1136/gut.2003.019984 – volume: 50 start-page: 2101 issue: 54 year: 2003 end-page: 2104 ident: CR7 article-title: Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study publication-title: Hepatogastroenterology – volume: 18 start-page: 499 issue: 6 year: 1972 end-page: 502 ident: CR14 article-title: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge publication-title: Clin Chem – volume: 8 start-page: 423 year: 2008 ident: CR30 article-title: High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population publication-title: BMC Public Health doi: 10.1186/1471-2458-8-423 – volume: 89 start-page: 137 issue: 2 year: 1996 end-page: 144 ident: CR8 article-title: Biochemical markers of alcohol abuse publication-title: QJM doi: 10.1093/qjmed/89.2.137 – volume: 28 start-page: 27 issue: 1 year: 2008 end-page: 38 ident: CR26 article-title: Fatty liver: a novel component of the metabolic syndrome publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.107.147538 – volume: 5 start-page: 59 issue: 2 year: 1991 end-page: 67 ident: CR25 article-title: Alcohol intake and variations in blood pressure by day of examination publication-title: J Hum Hypertens – volume: 37 start-page: 1202 issue: 5 year: 2003 end-page: 1219 ident: CR1 article-title: Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference publication-title: Hepatology doi: 10.1053/jhep.2003.50193 – year: 2005 ident: CR15 article-title: StataCorp: Stata Statistical Software publication-title: Release 9.0 – volume: 66 start-page: 101 issue: 2 year: 2007 end-page: 112 ident: CR29 article-title: National type 2 diabetes prevention programme in Finland: FIN-D2D publication-title: Int J Circumpolar Health doi: 10.3402/ijch.v66i2.18239 – volume: 366 start-page: 1059 issue: 9491 year: 2005 end-page: 1062 ident: CR13 article-title: The metabolic syndrome--a new worldwide definition publication-title: Lancet doi: 10.1016/S0140-6736(05)67402-8 – volume: 137 start-page: 1 issue: 1 year: 2002 end-page: 10 ident: CR16 article-title: Updated definitions of healthy ranges for serum alanine aminotransferase levels publication-title: Ann Intern Med doi: 10.7326/0003-4819-137-1-200207020-00006 – volume: 28 start-page: 629 issue: 4 year: 2008 end-page: 636 ident: CR22 article-title: Metabolic syndrome pandemic publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.107.151092 – volume: 37 start-page: 1202 issue: 5 year: 2003 ident: 2148_CR1 publication-title: Hepatology doi: 10.1053/jhep.2003.50193 – volume: 18 start-page: 1089 issue: 6 year: 2004 ident: 2148_CR5 publication-title: Best Pract Res Clin Gastroenterol doi: 10.1016/j.bpg.2004.06.021 – volume: 5 start-page: 59 issue: 2 year: 1991 ident: 2148_CR25 publication-title: J Hum Hypertens – volume: 176 start-page: 508 issue: 4 year: 1984 ident: 2148_CR23 publication-title: Proc Soc Exp Biol Med doi: 10.3181/00379727-176-4-RC2 – volume: 66 start-page: 101 issue: 2 year: 2007 ident: 2148_CR29 publication-title: Int J Circumpolar Health doi: 10.3402/ijch.v66i2.18239 – volume: 8 start-page: 423 year: 2008 ident: 2148_CR30 publication-title: BMC Public Health doi: 10.1186/1471-2458-8-423 – volume: 288 start-page: E462 issue: 2 year: 2005 ident: 2148_CR3 publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00064.2004 – volume: 90 start-page: 3498 issue: 6 year: 2005 ident: 2148_CR19 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2004-2240 – volume: 40 start-page: S5 issue: 3 Suppl 1 year: 2006 ident: 2148_CR4 publication-title: J Clin Gastroenterol – volume: 53 start-page: 750 issue: 5 year: 2004 ident: 2148_CR6 publication-title: Gut doi: 10.1136/gut.2003.019984 – volume: 28 start-page: 629 issue: 4 year: 2008 ident: 2148_CR22 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.107.151092 – volume: 92 start-page: 3490 issue: 9 year: 2007 ident: 2148_CR11 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2007-0482 – volume: 116 start-page: 1413 issue: 6 year: 1999 ident: 2148_CR18 publication-title: Gastroenterology doi: 10.1016/S0016-5085(99)70506-8 – volume: 45 start-page: 846 issue: 4 year: 2007 ident: 2148_CR28 publication-title: Hepatology doi: 10.1002/hep.21496 – volume-title: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus year: 1999 ident: 2148_CR12 – volume: 366 start-page: 1059 issue: 9491 year: 2005 ident: 2148_CR13 publication-title: Lancet doi: 10.1016/S0140-6736(05)67402-8 – volume: 42 start-page: 44 issue: 1 year: 2005 ident: 2148_CR17 publication-title: Hepatology doi: 10.1002/hep.20734 – volume: 41 start-page: 105 issue: 2 year: 1988 ident: 2148_CR10 publication-title: J Clin Epidemiol doi: 10.1016/0895-4356(88)90084-4 – volume: 18 start-page: 499 issue: 6 year: 1972 ident: 2148_CR14 publication-title: Clin Chem doi: 10.1093/clinchem/18.6.499 – volume: 137 start-page: 1 issue: 1 year: 2002 ident: 2148_CR16 publication-title: Ann Intern Med doi: 10.7326/0003-4819-137-1-200207020-00006 – volume-title: Release 9.0 year: 2005 ident: 2148_CR15 – volume: 100 start-page: 850 issue: 4 year: 2005 ident: 2148_CR20 publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2005.41500.x – volume: 50 start-page: 2101 issue: 54 year: 2003 ident: 2148_CR7 publication-title: Hepatogastroenterology – volume: 98 start-page: 960 issue: 5 year: 2003 ident: 2148_CR2 publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2003.07486.x – volume: 28 start-page: 27 issue: 1 year: 2008 ident: 2148_CR26 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.107.147538 – volume: 94 start-page: 1018 issue: 4 year: 1999 ident: 2148_CR21 publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.1999.01006.x – volume: 89 start-page: 137 issue: 2 year: 1996 ident: 2148_CR8 publication-title: QJM doi: 10.1093/qjmed/89.2.137 – volume: 37 start-page: 246 issue: 4 year: 2005 ident: 2148_CR9 publication-title: Horm Metab Res doi: 10.1055/s-2005-861411 – volume: 60 start-page: 79 issue: 1 year: 1986 ident: 2148_CR24 publication-title: Atherosclerosis doi: 10.1016/0021-9150(86)90090-0 – volume: 37 start-page: 399 issue: 5 year: 2003 ident: 2148_CR27 publication-title: J Clin Gastroenterol doi: 10.1097/00004836-200311000-00010 – reference: 18174459 - Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):629-36 – reference: 12093239 - Ann Intern Med. 2002 Jul 2;137(1):1-10 – reference: 15082596 - Gut. 2004 May;53(5):750-5 – reference: 15895401 - Hepatology. 2005 Jul;42(1):44-52 – reference: 15952086 - Horm Metab Res. 2005 Apr;37(4):246-51 – reference: 10348825 - Gastroenterology. 1999 Jun;116(6):1413-9 – reference: 12717402 - Hepatology. 2003 May;37(5):1202-19 – reference: 15784031 - Am J Gastroenterol. 2005 Apr;100(4):850-5 – reference: 6463061 - Proc Soc Exp Biol Med. 1984 Sep;176(4):508-11 – reference: 16540768 - J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S5-10 – reference: 17515250 - Int J Circumpolar Health. 2007 Apr;66(2):101-12 – reference: 3707675 - Atherosclerosis. 1986 Apr;60(1):79-87 – reference: 4337382 - Clin Chem. 1972 Jun;18(6):499-502 – reference: 3335877 - J Clin Epidemiol. 1988;41(2):105-14 – reference: 15561640 - Best Pract Res Clin Gastroenterol. 2004 Dec;18(6):1089-104 – reference: 8729555 - QJM. 1996 Feb;89(2):137-44 – reference: 14696473 - Hepatogastroenterology. 2003 Nov-Dec;50(54):2101-4 – reference: 17595248 - J Clin Endocrinol Metab. 2007 Sep;92(9):3490-7 – reference: 12809815 - Am J Gastroenterol. 2003 May;98(5):960-7 – reference: 1677046 - J Hum Hypertens. 1991 Apr;5(2):59-67 – reference: 17393509 - Hepatology. 2007 Apr;45(4):846-54 – reference: 15339742 - Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E462-8 – reference: 17690317 - Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):27-38 – reference: 19113993 - BMC Public Health. 2008;8:423 – reference: 14564188 - J Clin Gastroenterol. 2003 Nov-Dec;37(5):399-402 – reference: 10201476 - Am J Gastroenterol. 1999 Apr;94(4):1018-22 – reference: 15797948 - J Clin Endocrinol Metab. 2005 Jun;90(6):3498-504 – reference: 16182882 - Lancet. 2005 Sep 24-30;366(9491):1059-62 |
| SSID | ssj0017852 |
| Score | 2.2098236 |
| Snippet | Background
Non-alcoholic fatty liver disease (NAFLD) is known to be associated with the metabolic syndrome (MetS) and abnormal glucose tolerance. Whether... Non-alcoholic fatty liver disease (NAFLD) is known to be associated with the metabolic syndrome (MetS) and abnormal glucose tolerance. Whether alcoholic fatty... Background Non-alcoholic fatty liver disease (NAFLD) is known to be associated with the metabolic syndrome (MetS) and abnormal glucose tolerance. Whether... Abstract Background: Non-alcoholic fatty liver disease (NAFLD) is known to be associated with the metabolic syndrome (MetS) and abnormal glucose tolerance.... Abstract Background Non-alcoholic fatty liver disease (NAFLD) is known to be associated with the metabolic syndrome (MetS) and abnormal glucose tolerance.... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 237 |
| SubjectTerms | Adult Biostatistics Blood & organ donations Clinical medicine Comorbidity Confidence intervals Diabetes Diabetes Mellitus, Type 2 - epidemiology Diagnosis Disease Environmental Health Enzyme kinetics Epidemiology Ethanol Fatty liver Fatty Liver - epidemiology Fatty Liver - metabolism Fatty Liver, Alcoholic - epidemiology Female Finland Glucose Intolerance - epidemiology Glucose tolerance tests Health surveys Hospitals Humans India - epidemiology Insulin resistance Internal medicine Liver Liver diseases Male Medicine Medicine & Public Health Mens health Metabolic disorders Metabolic Syndrome - epidemiology Methods Middle Aged Mortality Population studies Prevalence Public Health Research Article Spectrum analysis Surveys Type 2 diabetes Vaccine Womens health |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Li9RAEG5k8SCI-DbuKn0QRCFM3t3tbXQcFNZBWIW9Nf3EhSWRSWZl_4q_1qqkk52sqBeP6UeS7qpUf5Wu_oqQF4ZxlwidxNwoGxewQMQcST_TxHpuWKEK1x8UPmabDT89FZ_3Un1hTNhADzxM3CJjXgOmThFrF67kgqsk1za1mVPgUlm0voB6Rmcq7B8w3ufaScH0xllR8nGDkleLqQwtUIb5z_cWpJ63_3frvLc8XQ-dvLZ_2i9L67vkTsCTdDmM4x654er75PbwM44OZ4wekJ-bpo7VkAwXilVt6dXVWnXdJT3G-Ay6GrZraEy7H8141dLG06UPyUyoCgJ1luJPXAoIkn5yHSgT3u0kMCD0D0Enl2Y0RN20b_q264-beJWt6Mlue-EuH5Kv6_df3n2IQ1KG2IDv0cWea3A8y1JrBa4Uy5QRwjnAIV6nzvDEGluJSnmfcS-c9qX3mlnhTK5yYb3JH5GDuqndE0IFUqNWqkgdHuhVTCkAh-BRYZbAQnMdkcUoGWkCYzkmzjiXvefCK4mylChLLAFZRuTV1OP7wNbxl7ZvUdhTO-TZ7gtA-2TQPvkv7YvIS1QVidYAXs2ocKgBBoi8WnIJ6BYgKICoiBzNWsJXbGbVh6OyyWBFWikAgAnkaIwInWqxIwbG1a7ZtZLlABhzXiUReTxo5jQgTDQgWAad2UxnZyOe19Rn33qGcXCjkSgxIq9H7b56qT_N59P_MZ-H5NYYnpEmR-Sg2-7cM3LTXHRn7fZ5_43_Ah-AUBA priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEF5BygEJ8S6YFrQHJASSFb93lwtKSSOQSlRRkHqz9gmVkF1ip6h_hV_LjL12myJ64eh9JJ7k29mZndlvCHmpGbeRUFHItTRhBhtEyJH0M46M45plMrPdReEDtlzy42Nx6HNzGp9WOejETlGbWuMZ-VTAZiSQr-7d6c8Qi0ZhcNVX0LhJtpCoLJuQrb395eHnMYzAeJ4MsUleTGPQxGGS5R2haYKlzy_tRR1l_9-K-dLOdDVr8krotNuRFvf-U5b75K43Remsx84DcsNWD8md_hyP9teTHpHfy7oKZV9HF5plZejF00K27Tk9wNQOOu8jPTSk7a96eGpo7ejM-TooVHosWEPx_JeC8Uk_2RZwiJ925MkTui9B_5gm1CfsNG-7sYuPy3CezOnRenVmzx-Tr4v9L-8_hL6eQ6jBbWlDxxX4rHmulAQvjCVSC2EtmDBOxVbzyGhTiEI6l3AnrHK5c4oZYXUqU2GcTrfJpKor-5RQgayqhcxii3eBJZMS7EpwxrDAYKa4Csh0-GdL7cnOsebGj7JzenhRIhZKxAK2ABYC8nqccdoTfVwzdg_BMo5Diu6uoV59K_2KLxPmFDiDMTqJmc254DJKlYlNYmWUMBOQVwi1EhUJvJqW_j4ECIiUXOUMDGOwXsH-CsjuxkhQAHqje2dAWekVUFOOEAsIHXtxIubUVbZeNyVLwdZMeREF5EmP7FEgrFEgWAKT2QbmNyTe7KlOvnfk5OCBI8diQN4Mq-Pipf71ez67VoIdcntI2YijXTJpV2v7nNzSZ-1Js3rhl_wfr0FdkQ priority: 102 providerName: ProQuest |
| Title | Non-alcoholic and alcoholic Fatty Liver Disease - two Diseases of Affluence associated with the Metabolic Syndrome and Type 2 Diabetes: the FIN-D2D Survey |
| URI | https://link.springer.com/article/10.1186/1471-2458-10-237 https://www.ncbi.nlm.nih.gov/pubmed/20459722 https://www.proquest.com/docview/902190342 https://www.proquest.com/docview/733553860 https://pubmed.ncbi.nlm.nih.gov/PMC2873937 https://doaj.org/article/27fb875100964e5898a03bd1d2ea027d |
| Volume | 10 |
| WOSCitedRecordID | wos000278254500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMedCentral customDbUrl: eissn: 1471-2458 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017852 issn: 1471-2458 databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1471-2458 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017852 issn: 1471-2458 databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1471-2458 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017852 issn: 1471-2458 databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Engineering Database (Proquest) customDbUrl: eissn: 1471-2458 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017852 issn: 1471-2458 databaseCode: M7S dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com providerName: ProQuest – providerCode: PRVPQU databaseName: Environmental Science Database customDbUrl: eissn: 1471-2458 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017852 issn: 1471-2458 databaseCode: PATMY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/environmentalscience providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 1471-2458 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017852 issn: 1471-2458 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest One Academic customDbUrl: eissn: 1471-2458 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017852 issn: 1471-2458 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Public Health Database customDbUrl: eissn: 1471-2458 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017852 issn: 1471-2458 databaseCode: 8C1 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content customDbUrl: eissn: 1471-2458 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017852 issn: 1471-2458 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1471-2458 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017852 issn: 1471-2458 databaseCode: RSV dateStart: 20011201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3rb9MwED_tgRAS4jEGhI3KH5AQSNHyrG2-desqJq1VtQIanyLHsWESSlGbDu1f4a_lzkk6Mh4SfIkUPxq7Pt_Dd_4dwAvNhQlkHvhCq8JPUED4gkA_w6CwQvNEJcZdFD7lk4k4P5fTDYjauzAu2r11STpO7ba16B-EyEb9KEkdGmkU803YRmEnaDOezT6sPQdcpFHrjvxNr474cSj9v_Lin4TRzUDJG95SJ4RG9_9n-A_gXqNyskFNIw9hw5Q7cHvcONV34G59dMfqG0mP4PtkXvqqTp2Lxaos2PXbSFXVFTulaA42rJ07zGfVt3n7tmRzywa2SX3CVLP8pmB05MtQ32RjUyHp0a_NGrwE9xEyiVnEmhid5RvXdnQy8YfRkM1Wi0tztQvvR8fvjt76TQoHX6OlUvlW5GimpmmeKzS8eKS0lMag1mLz0GgRFLroy76yNhJWmtym1ua8kEbHKpaF1fFj2CrnpXkKTBKQal8loaHrv4orhaok2l-UUzDJRe7BQbuymW7wzSnNxpfM2Tmin9ESZLQEVIJL4MGrdY-vNbbHX9oeErGs2xEqtyuYLz5lzSbPIm5ztP9CsgsTkwopVBDnRVhERqH5X3jwkkgtI96BQ9OquQKBEyQUrmyAujAqrKhyebDfaYl7Xneq91pizRqes8wkqmuSEB09YOta6khhdKWZr5YZj1G9jEU_8OBJTdnrCVFaAskj7Mw7NN-ZcbemvPjs8MjR6CZYRQ9et5R_Pag__Z_P_qXxHtxpgzbCYB-2qsXKPIdb-rK6WC56sMnPuXsKfIqjsAfbh8eT6VnPHbD0KJx3hmXTk_H0Y89xix_QtVwu |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLZGhwQS4n4JG-AHEAIpauKkjY2EUKFUq9ZWlTak7ck4jg2TUDKadFP_Cv-B_8g5uW0dYm974DG-JXa-c7OPzyHkpY648UTsuVyrxA1BQLgcg376XmK5jkIVmvKi8CSazfjBgZhvkN_NXRh0q2x4Ysmok0zjHnlXgDASGK_uw_FPF5NG4eFqk0GjQsWuWZ2CxZa_Hw_h975ibPR5_9OOWycVcDXozoVreQyGU68XxwpMgYgpLYQxIEdt7BvNvUQnfdFX1jJuhYltz9o4SoTRgQpEYnUA414jmyFgnXfI5nw8nR-2xxYwMGvOQnm_C-P7Lgt7ZQBVhqnWz8m-MkXA34LgnCS86KV54ai2lICjO__Z2t0lt2tVmw4q2rhHNkx6n9yq9ilpdf3qAfk1y1JXVXmCoVilCT17GqmiWNEJuq7QYXWSRV1anGbNU04zSwe2zvNCVY11k1Dc36agXNOpKYDOcLS9OjhE-RK0_ymjtUNS_q5sOxrP3CEb0r3l4sSsHpIvV7I8j0gnzVLzhFCBUWP7KvQN3nVWkVKgN4OxiQkUw5jHDuk2SJK6DuaOOUV-yNKo432J2JOIPSwB7DnkTdvjuApkcknbjwjOth2GIC8LssU3WXM0ySIbg7HroxEcmh4XXHlBnPgJM8pjUeKQ1whtiYwSPk2r-r4HTBBDjskBKP6gnYN-6ZDttZbA4PRa9VaDalkz2Fy2kHYIbWuxI_oMpiZb5jIKQJcOeN9zyOOKktoJYQ4GETHoHK3R2NqM12vSo-9l8HXGyxiSDnnbUOPZR_1rPZ9eOoMX5MbO_nQiJ-PZ7ha52bin-N426RSLpXlGruuT4ihfPK_ZDSVfr5pK_wDlpsAA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3rb9MwELdgoAkJ8RgDwgb4AxICKWretvlWKBUTXTWpgPbNcvyASSiZ2nRo_wp_LXeJ05HxkBAfY5_bOD6f73x3vyPkmWbcRqKMQq6VCTM4IEKOoJ9xZBzXLFOZbROFZ2w-58fH4shfuK36aPfeJdnlNCBKU9WMTo3rtjgvRjGI1DDJ8haZNEnZVXItw5JBaK0vPm28CIznSe-a_M2owVHUIvb_Kpd_OpguB01e8py2B9L09v9O5Q655VVROu545y65Yqsdsn3one075GZ3pUe7TKV75Pu8rkLVldSFZlUZevE0VU1zTmcY5UEnndOHhrT5VvdPK1o7Ona-JApVni2soXgVTEEPpYe2AZbEX1t4HIX2T9BUpgn1sTurVy3t9GAeTpIJXayXZ_Z8l3ycvv3w5l3oSzuEGiyYJnS8BPM1z8tSgUHGEqWFsBa0GVfGVvPIaFOIQjmXcCds6XLnSmaE1alKhXE6vU-2qrqyDwkVCLBaqCy2mBasmFKgYoJdhrUGs5KXARn1qyy1xz3H8htfZWv_8ELiEkhcAmyBJQjIi82I0w7z4y-0r5FxNnSI1t021MvP0m9-mTBXgl0Yo72Y2ZwLrqK0NLFJrIoSZgLyHNlOokyBV9PKp0bABBGdS45BRwZFFlSxgOwPKEEW6EH3Xs-40suilRSgxglEegwI3fTiQAyvq2y9XkmWgtqZ8iIKyIOOyzcTwnIFgiUwmA34fzDjYU918qXFKQdjHOEWA_Ky3wUXL_Wn7_noX4ifku2jyVTODubv98iNPq4jjvbJVrNc28fkuj5rTlbLJ61Y-AG9e2Ah |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Non-alcoholic+and+alcoholic+Fatty+Liver+Disease+-+two+Diseases+of+Affluence+associated+with+the+Metabolic+Syndrome+and+Type+2+Diabetes%3A+the+FIN-D2D+Survey&rft.jtitle=BMC+public+health&rft.au=Kotronen%2C+Anna&rft.au=Yki-J%C3%A4rvinen%2C+Hannele&rft.au=M%C3%A4nnist%C3%B6%2C+Satu&rft.au=Saarikoski%2C+Liisa&rft.date=2010-05-10&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2458&rft.eissn=1471-2458&rft.volume=10&rft.spage=237&rft_id=info:doi/10.1186%2F1471-2458-10-237&rft.externalDocID=A226839124 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2458&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2458&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2458&client=summon |